A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
暂无分享,去创建一个
T. Naoe | H. Tanii | J. Ishikawa | I. Jinnai | K. Miyamura | Y. Miyazaki | K. Ohyashiki | A. Tojo | T. Hughes | T. Kawaguchi | A. Urabe | M. Okada | S. Branford | S. Okamoto | Y. Maeda | Hideo Tanaka | M. Nishimura | K. Usuki | N. Usui | Taro Amagasaki | H. Natori | Y. Kobayashi | T. Hughes